ISSN 1025-0298 |
|
Basic information
Organism: Finlay Ediciones Frequency: Annual volume (continuous publication) Foundation: 1992 Readers and authors: Professionals and technicians in the field of Health and Biological Sciences. Object of study: All concerning Vaccinology. There are also included subject matters of Immunology, Adjuvants, Infectious Diseases, Microbiology, Epidemiology, Programs of Vaccinations, Preclinical and Clinical Trials, Molecular Biology, Bioinformatics, Experimental Biomodels, Immunodiagnostics, Production Technologies, Validation, Quality Assurance and regulatory Aspects. Mission: To spread the scientific results on vaccines of national and international institutions and this way to contribute to the visibility of this sector of the science in Cuba and other countries. Ethical Issues: VacciMonitor publishes the results of research involving human subjects only if such research has been conducted in full accordance with ethical principles, including the provisions of the World Medical Association Declaration of Helsinki. Any manuscript describing the results of such research that is submitted for publication must contain a clear statement to this effect, specifying that the free and informed consent of the subjects or their legal guardians were obtained and that a qualified ethical review board approved the investigation. When reporting experiments on animals, authors must indicate whether the welfare of animals used in scientific experiments was taking into account, and if the institutional and national guide for the care and use of laboratory animals were followed. No responsibility is assumed by the Publisher House for the authorship of the papers, and any methods, products, instructions or ideas contained in papers. Conflict of interest: A conflict of interest arises when a professional judgement concerning the validity of the research tends to be influenced by any self-interested motive. Authors should disclose at the time of submission information on financial conflicts of interest that may influence the manuscript. They may also declare other conflicts that could influence the results of the study or the conclusions of the manuscript. Autor contributions: Each author must declare his/her individual contribution to the article, according to the CRediT methodology. All must have materially participated in the research and/or preparation of the article. Roles are available at: https://casrai.org/credit/, and describe each contributor's specific contribution to the scholarly output, according to: Conceptualization, Data Curation, Formal Analysis, Fund Acquisition, Research, Methodology, Project Management, Resources, Software, Supervision, Validation, Visualization, Original Drafting-Drafting, Drafting-Revising, and Editing.The statement that all authors approved the final article must be true and included in this section, which should be placed before the references. Clinical Trials: They must be previously registered and carried out according to international requirements. Papers must include a format for results reporting, like CONSORT Guidelines. Peer review process: Papers sent to VacciMonitor for publication are initially evaluated by the executive editor and the Editorial Board to check whether they are in accordance to the aims and scope of the Journal. Then, papers are submitted to the impartial review process. All contributions are reviewed by two high-level referees –peer review– and double-blind is guaranteed. The referees´ report must be finished in a minimum of 15 working days . If there is any conflict of interest, or contradictory reports, a third referee is designed. On acceptance, contributions are submitted to the author with recommendations, or general comments. The author should correct them and submit them again. Papers are reviewed again by the referees, and so on. Finally, contributions are subjected to editorial amendment to suit house style. Statistical analyses are reviewed by our referees, according to our guidelines, as well as a Biostatistician. This journal is in favor of the principles of Open Science that promotes transparency in the manuscript evaluation process, so it may use open peer review methods, with the prior authorization of the authors and referees. |
Indexed in
EBSCO Information Services (USA), SCOPUS, Directory of Open Access Journals (DOAJ), SciELO (Scientific Electronic Library Online), Redalyc, Free Medical Journals (USA), HINARI (Health InterNetwork), SIIC Data Bases, MedicLatina, Latindex, Fuente Académica, Periódica (México), Network University Libraries (USA), Columbia University Libraries, New York University School of Medicine, University of Illinois at Urbana-Champaign Library Gateway, Catalogue du SCD de Rennes (France), Catálogo-Universidad Veracruzana, (SeCimed) Cuba, Catálogo Colectivo de Publicaciones Seriadas de Ciencias de la Salud (Cuba). Electronic Format: XML/PDF. |
Open Science Policy
In support of Open Science, VacciMonitor accepts manuscripts that have been posted in a preprint archive. A preprint is a draft version of a paper made available online before submission to a journal. In addition, the journal provides immediate open access to its content, based on the principle that providing the public with free access to research helps to increase the global exchange of knowledge. Access to all contents of the journal, registration and submission of articles is completely free of charge. All article processing, review, editing and publication is free of charge for authors. VacciMonitor, as an open access journal, grants authors full permission to freely dispose of their article, as described in Copyright. Open Data Policy The journal promotes the openness of research data, as long as the level of confidentiality allows it. As part of the compliance with the principles of Open Science, the author may submit their research data in any of the servers available internationally for this purpose, which ensures compliance with the FAIR (Findability, Accessibility, Interoperability, and Reusability) principles. |
Copyright
VacciMonitor is an open Journal under Creative Commons license CC-BY-NC. Permissions are granted to authors: a) Authors can distribute electronic or print copies of the published article among students or colleagues, including the authorization to be used for educational purposes by other specialists of the institution. b) Re use the whole article or a part of it in new manuscripts or future books. c) Authors are authorized by VacciMonitor to use either their version or the one edited by the Journal in their personal website or in any other free-access repository. d) VacciMonitor authorizes other publishing houses or databases to reproduce the published original materials if the journal source is mentioned.
|
Sponsors
The publishing of the journal is financed by: Finlay Institute of Vaccines www.finlay.edu.cu The journal is scientifically sponsored by: Cuban Society of Immunology www.sci.sld.cu Cuban Society of Pharmacology www.scf.sld.cu |
[Home] [Editorial Team] [Instructions to authors] [Subscription]
All the content of this journal is licensed under https://creativecommons.org/licenses/by/4.0/deed.es_ES
The journal has open and free access.
Address:
“Finlay Ediciones”. Ave. 27 No. 19805. La Lisa. La Habana, Cuba. CP 11600, AP 16017.
Phones: (53) 7-2719123; (53) 7-2080982